Company intelligence / Profile preview

Sichuan Huiyu Haiyue Pharmaceutical Technology Co., Ltd.

Neijiang City, Sichuan Sheng, Chinaen.huiyupharma.com ↗

Ownership: Private
Development stage: Other

Overview

Huiyu Haiyue is advancing innovative biologic drugs such as HY07121/HY0007—a bispecific antibody fusion targeting IL‑15Rα, PD‑L1, and TIGIT—into early clinical trials for advanced solid tumors. The subsidiary leverages advanced glycan profiling technologies in its development process. Its parent company has a broader portfolio including approved generics and APIs with international regulatory certifications[3][4][5].

Therapeutic areas: Oncology
Modalities: Small moleculesAntibody fusion proteins (e.g. bispecific antibodies)Biological products
Industry: Biotech

Partnerships

Collaboration with Hzymes Biotech for glycan analysis technology in drug developmentParent company also engages in global partnerships for API/generics distribution.

Beyond the preview

Go deeper on Sichuan Huiyu Haiyue Pharmaceutical Technology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sichuan Huiyu Haiyue Pharmaceutical Technology Co., Ltd..

Explore the full profile